NIH-funded research NIH-funded research

Understanding how genes interact with their regulatory elements in 3D space

Official title: Genetic and Epigenetic Controls of Enhancer-Promoter Interactions

Funded at University of Chicago · NIH-10842795 · Data updated 2026-11-12

This study is looking at how certain parts of our DNA, called enhancers, help control genes from a distance, which is important for understanding how our bodies develop and how some cancers happen, so that patients can gain insights into the genetic reasons behind these issues.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 2, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$445,033
NIH project number1R35GM153238-01
Project IDNIH-10842795 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with developmental abnormalities or cancers that may be linked to genetic regulatory disruptions.

Less likely to help

Patients with conditions unrelated to genetic regulation or those not affected by developmental abnormalities or cancers may not receive benefits from this research.

What this research studies

This research investigates how genes are regulated by enhancers that can be located far away from the genes they control, particularly in the context of embryonic development and cancer. By examining the 3D structure of the genome, the study aims to uncover the mechanisms that dictate how these enhancers and promoters interact. The research employs advanced genomic tools to analyze the genetic sequences and structural features that influence these interactions, which are crucial for proper gene expression. Patients may benefit from insights gained into the genetic causes of developmental abnormalities and cancers linked to these regulatory mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for diagnosing and treating developmental disorders and cancers by targeting the underlying genetic regulatory mechanisms.

How similar studies have gone: Other research has shown promising results in understanding gene regulation through 3D genome architecture, indicating that this approach has potential for significant discoveries.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Spitz, Francois — University of Chicago
  • Study coordinator: Spitz, Francois

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.